Back to Rare Disease
NCT05961267
NCT05961267
Who may be able to join
Who might be able to join this trial:
- You are a woman aged 18 or older
- You have not yet gone through menopause (this applies only to a specific subgroup within the trial related to contraception use)
- You have been diagnosed with one of the following conditions: systemic lupus erythematosus, Gougerot-Sjögren's syndrome, scleroderma, Sharp's syndrome, rheumatoid arthritis, or spondyloarthritis, based on current international medical standards
- You speak French and have no difficulties understanding the study information
- You are covered by or benefit from a social security scheme (French healthcare coverage)
- You have been informed about the trial and have agreed to take part
Who may not be able to join:
- You are currently pregnant or breastfeeding
- You have had a complete surgical removal of your womb (total hysterectomy)
- You are a minor, are deprived of liberty by a legal or administrative decision, or are under a legal protection measure or are unable to give your own consent (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Bordeaux
Registry
clinicaltrials_gov
Start date
24 July 2023
Est. completion
28 June 2024
Where this trial is recruiting
🇫🇷 France
Primary endpoints
Proportion of patients who report having a screening of cervical dysplasia during the year according to international recommendations.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.